早孕期血糖检测预测妊娠期糖尿病与大于胎龄儿出生体重
GO MOMs前瞻性队列纳入2178例无孕前糖尿病的单胎孕妇,在孕10-14周行盲法75g OGTT和CGM,评估早孕期血糖指标能否在临床因素基础上改善妊娠期糖尿病(GDM)和大于胎龄儿(LGA)的预测。结果显示,在NPV≥96%、GDM患病率8.3%条件下,OGTT联合临床因素使GDM的PPV从12.2%升至26.5%,CGM联合临床因素升至19.8%,但两者均未改善LGA预测。
要点
- 早孕期OGTT或CGM联合临床因素可改善GDM预测,但不改善LGA预测。
- 在GDM患病率8.3%时,OGTT联合临床因素使GDM的PPV从12.2%升至26.5%。
- CGM联合临床因素使GDM的PPV升至19.8%,低于OGTT联合方案。
核心结论
- 在具有美国代表性的人群中,将孕10-14周OGTT或CGM标准加入临床因素可改善GDM预测,但不改善LGA预测。
研究设计与样本
- GO MOMs为前瞻性观察性研究,在美国九个中心(2021-2025)纳入单胎妊娠且无孕前糖尿病的孕妇2178例。
- 参与者在孕10-14周接受盲法75-g OGTT和CGM,并在孕24-28周评估GDM、产后评估LGA。
- 预测模型在四个中心的数据中训练、在五个中心验证,比较OGTT或CGM标准联合临床因素与单纯临床因素的PPV。
主要发现
- 2178例参与者中,93.3%在孕24-28周完成OGTT(GDM 15.4%),98.1%活产儿有LGA判定数据(LGA 11.2%)。
- 在NPV≥96%、GDM患病率8.3%时,GDM的PPV:临床因素 alone 12.2%(95%CI 11.0-13.3%),OGTT联合临床因素26.5%(23.1-30.3%),CGM联合临床因素19.8%(17.2-22.5%)。
- 对于LGA,两种血糖模型均未改善PPV;验证集确认了上述发现。
关键数值与推荐
- GDM预测的PPV比较在预设NPV≥96%、全国GDM患病率8.3%条件下进行。
- LGA预测的PPV比较在预设NPV≥96%、LGA患病率10%条件下进行。
临床怎么用
- 早孕期OGTT或CGM联合临床因素可用于提升GDM预测,但不应期望其改善LGA预测。
- 未来研究需确定早孕期预测GDM是否能促成改善GDM相关妊娠结局的干预。
局限性
- 原始摘要未报告模型校准度、具体血糖阈值及CGM指标定义。
- 原始摘要未报告研究人群的种族/民族构成细节及干预可行性数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated whether early pregnancy oral glucose tolerance testing (OGTT) or continuous glucose monitoring (CGM) improves gestational diabetes mellitus (GDM) or large-for-gestational-age (LGA) birth prediction over clinical factors alone. RESEARCH DESIGN AND METHODS: In the Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs) study, a prospective observational study at nine U.S. sites (2021-2025), participants with singleton gestation and without preexisting diabetes underwent blinded 75-g OGTT and CGM at 10-14 weeks' gestation. Predictive models for GDM at 24-28 weeks and LGA were developed using these data and clinical factors (maternal age, BMI, GDM or macrosomia history). New glycemic criteria maximized the area under the receiver operating characteristic curve in training data from four sites and were validated in five. Models incorporating OGTT or CGM criteria versus clinical factors alone compared positive predictive value (PPV) at a prespecified negative predictive value (NPV) at a reported 8.3% national GDM prevalence and 10% for LGA. RESULTS: Of 2,178 participants, 93.3% who were pregnant at 24-28 weeks completed OGTTs (15.4% GDM), and 98.1% with live births had data to determine LGA (11.2% LGA). At NPV ≥96% and 8.3% GDM prevalence, PPV for GDM was 12.2% (95% CI 11.0-13.3%) for clinical factors alone, 26.5% (23.1-30.3%) for OGTT plus clinical factors, and 19.8% (17.2-22.5%) for CGM plus clinical factors. For LGA, neither glycemic model improved PPV. Validation confirmed findings. CONCLUSIONS: In a U.S.-representative population, adding 10- to 14-week OGTT or CGM criteria to clinical factors improved GDM but not LGA prediction. Future studies should determine whether predicting GDM in the first trimester facilitates interventions that improve GDM-related pregnancy outcomes.
引用
- Early Pregnancy Glycemic Testing for Prediction of Gestational Diabetes Mellitus and Large-for-Gestational-Age Birth Weight. Diabetes Care. 2026. PMID: 42251767. doi:10.2337/dc26-0302
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。